DIVA Laboratories, Ltd. (TPEX:4153)
Taiwan · Delayed Price · Currency is TWD 32.00
-0.15 (-0.47%)
Apr 20, 2026, 1:24 PM CST
DIVA Laboratories Revenue
In the year 2025, DIVA Laboratories had annual revenue of 868.84M TWD with 0.76% growth. DIVA Laboratories had revenue of 229.72M in the quarter ending December 31, 2025, with 2.89% growth.
Revenue
868.84M
Revenue Growth
+0.76%
P/S Ratio
2.16
Revenue / Employee
5.64M
Employees
154
Market Cap
1.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 868.84M | 6.52M | 0.76% |
| Dec 31, 2024 | 862.32M | -31.52M | -3.53% |
| Dec 31, 2023 | 893.84M | -55.36M | -5.83% |
| Dec 31, 2022 | 949.20M | 236.97M | 33.27% |
| Dec 31, 2021 | 712.23M | -24.69M | -3.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| PharmaEssentia | 15.63B |
| BenQ Medical Technology | 5.25B |
| OK Biotech | 1.56B |
| TSH Biopharm Corporation | 1.34B |
| Medical Imaging | 1.16B |
| Crystalvue Medical | 949.05M |
| Caliway Biopharmaceuticals | 38.04M |